NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research ChannelBioSpace Collaborative Employers
 Post Job | Search Resumes | Login

 Top Breaking News
 Saturday, September 04, 2010

Ads for Sepracor's Lunesta, Novartis Corporation (NVS)'s Tasigna Among Those Warned by FDA    More...

AstraZeneca PLC (AZN)'s Seroquel XR Gets EC Approval    More...

BioDelivery Sciences International (BDSI) Calls Meeting With FDA Positive; BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug    More...

Celgene (CELG) Seeks To Stop Natco Pharma Limited's Generic Revlimid; Officially Notified of ANDA Filing Today    More...

FDA Staff Say Forest Laboratories, Inc. (FRX) Antibiotic Seems Effective    More...

FDA Warns On Increased Death Risk With Pfizer Inc. (PFE) Antibiotic Tygacil    More...

Actavis Receives FDA Approval of Atomoxetine HCl Capsules    More...

Abbott Laboratories (ABT)'s Diet Drug Meridia Study Shows Drug Raises Heart Attack, Stroke Risk; Renews Calls For U.S. Ban    More...

More News



 Market Summary

 Yesterday's Most Popular News 
'Brain Exercise' May Worsen Existing Alzheimer's, Rush University Medical Center Study    More...

Cancer Drug Gleevec May Offer Clue to Alzheimer's Cure, Study Published in Nature    More...

FDA Warns On Increased Death Risk With Pfizer Inc. (PFE) Antibiotic Tygacil    More...

New Evidence that Fat Cells are Not Just Dormant Storage Depots for Calories, Study Published in Journal of Proteome Research    More...

Actavis Receives FDA Approval of Atomoxetine HCl Capsules    More...

Abbott Laboratories (ABT)'s Diet Drug Meridia Study Shows Drug Raises Heart Attack, Stroke Risk; Renews Calls For U.S. Ban    More...

Pharmasset, Inc. (VRUS)'s PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection    More...

Is Lower Thyroid Activity Linked to Longevity? - Leiden University Medical Center Study    More...

AIDS Cure Quest to Kill 'Sleeping' Viruses Enlists Merck & Co., Inc. (MRK) Cancer Medicine, University of North Carolina Study    More...

Cardiome Pharma Corp. (COM.TO) Gets Nod For Marketing Heart Drug In EU; Receives $30 Million From Merck Sharp & Dohme (MRK)    More...


 
Job Search     

Advanced Search

 Featured Stories
 
Common Bone Drugs Linked to Esophageal Cancer Risk, University of Oxford Study    More...
Hair Provides Proof of the Link Between Chronic Stress and Heart Attack, University of Western Ontario Study    More...
Double-Dose Plavix Benefits Certain Patients, Columbia University Study Finds    More...
Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice, University of Texas MD Anderson Cancer Center Study    More...
Study Links Intermediary Cells to Triple-Negative Breast Cancer, Breakthrough Breast Cancer's Institute of Cancer Research Study    More...
Age No Barrier to Oral Anticoagulants, University of Birmingham Study    More...
Protecting the Lungs Against 'Collateral Damage' from the Immune System, University of Alabama at Birmingham Study    More...
European Society of Cardiology: Pre-Procedure Statins May Cut MI Risk, University of Florida Study    More...
More Featured Stories


 Featured Employer
Founded on the principle that strong science would lead to important new medicines, Regeneron has become an integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. Regeneron currently markets ARCALYST® (rilonacept) Injection for Subcutaneous Use for the treatment of a rare, inherited, inflammatory condition. Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, age-related macular degeneration, central retinal vein occlusion, and certain cancers. Additional therapeutic candidates are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic conditions, and cancer.

Show me jobs for this employer

 Careers
 
Top 20 Common Interview Questions and Answers    More...

Managing Older Managers: A Guide for Younger Bosses    More...

Best Questions To Ask In Your Job Interview    More...

Six Ways To Write Cover Letters They Won't Throw Out    More...

How To Beat The Negative Thoughts Ruining Your Job Search    More...

5 Strategies For Surviving The 'New Normal' Job Market    More...

The Young and Successful Job Search    More...

The Art Of Writing A Cover Letter    More...

Job Hunting Online: What To Do And What Not To Do    More...

Affirmative Action: How Far Have We Come?    More...

More Career Tips